Senti Biosciences

Senti Biosciences is a clinical-stage biotechnology company that specializes in the development of next-generation cell and gene therapies. The company's approach is centered around its proprietary gene circuit platform technology, which allows for the programming of therapeutic cells to respond to specific disease targets and microenvironments.

Senti Bio's primary focus is on the treatment of cancers, with a pipeline of product candidates designed to address various hematologic malignancies and solid tumors. The company is leveraging its platform to create "smarter" medicines that can be controlled and programmed to execute a wide range of therapeutic functions. Its business model revolves around the research and development of these therapies, with the ultimate goal of bringing them to market and providing new treatment options for patients with incurable diseases.

Keywords: biotechnology, cell therapy, gene therapy, gene circuit, oncology, clinical-stage, immunotherapy, synthetic biology, cancer treatment, therapeutics